Sublingual flunarizine: a new effective management of the migraine attack. A comparison versus ergotamine.
D000284:Administration, Oral; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002936:Cinnarizine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004878:Ergotamine; D004879:Ergotamines / Q000627:therapeutic use*; D005260:Female; D005444:Flunarizine; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy*; D011897:Random Allocation
D002121:Calcium Channel Blockers; D004879:Ergotamines; D002936:Cinnarizine; D004878:Ergotamine; D005444:Flunarizine